Akèy › Kansè pwostat rezistan a kastasyon › North Carolina
Etid klinik pou Kansè pwostat rezistan a kastasyon nan North Carolina
4 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan North Carolina.
Tèks ofisyèl etid la (Anglè)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Duke University Medical Center, Durham
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Levine Cancer Institute, Charlotte
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07164443A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Duke Cancer Institute, Durham
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Aug 10, 2026 · NCT06067841Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer
- W.G. Bill Hefner VA Medical Center, Salisbury
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Apr 13, 2026 · NCT04337580Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.